 36 PM / Updated 28 minutes ago BRIEF-Halozyme Projects 25 To 30 Percent Enhanze Royalty Growth In 2018 Reuters Staff 
Jan 9 (Reuters) - Halozyme Therapeutics Inc: 
* HALOZYME PROJECTS 25 TO 30 PERCENT ENHANZE ROYALTY GROWTH IN 2018 
* HALOZYME THERAPEUTICS INC - ‍ FORECASTS POTENTIAL ROYALTY REVENUE FOR ENHANZE TO REACH NEARLY $1 BILLION IN 2027 ​ 
* HALOZYME THERAPEUTICS INC - ‍EXPECTS ADDITIONAL PARTNERS TO BEGIN THREE PHASE 1 STUDIES WITH NEW TARGETS FOR ENHANZE​ IN 2018 Source text for Eikon: Further company coverage: